A detailed history of Iconiq Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Iconiq Capital, LLC holds 14,045 shares of AZN stock, worth $1.05 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,045
Previous 5,941 136.41%
Holding current value
$1.05 Million
Previous $462,000 99.13%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$63.2 - $79.58 $512,172 - $644,916
8,104 Added 136.41%
14,045 $920,000
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $455,496 - $520,550
5,941 New
5,941 $462,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $231B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Iconiq Capital, LLC Portfolio

Follow Iconiq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iconiq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iconiq Capital, LLC with notifications on news.